Inomagen Therapeutics has filed a notice of an exempt offering of securities to raise $6,626,079.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Inomagen Therapeutics is raising up to $6,626,079.00 in new funding. Sources indicate that as part of senior management President, Rishi Arora played a key role…